<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0000921895-26-000850</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Chernett Jorey -->
          <cik>0002042077</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>Common Stock, $0.01 par value</securitiesClassTitle>
      <dateOfEvent>05/19/2026</dateOfEvent>
      <previouslyFiledFlag>true</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001227636</issuerCIK>
        <issuerCusips>
          <issuerCusipNumber>64131A105</issuerCusipNumber>
        </issuerCusips>
        <issuerName>Neuronetics, Inc.</issuerName>
        <address>
          <com:street1>3222 PHOENIXVILLE PIKE</com:street1>
          <com:city>MALVERN</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19355</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Jorey Chernett</personName>
          <personPhoneNum>(248) 469-8811</personPhoneNum>
          <personAddress>
            <com:street1>6222 Indianwood Tr.</com:street1>
            <com:city>Bloomfield Hills</com:city>
            <com:stateOrCountry>MI</com:stateOrCountry>
            <com:zipCode>48301</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0002042077</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Chernett Jorey</reportingPersonName>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>10553988.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>10553988.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>10553988.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>15.17</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, $0.01 par value</securityTitle>
        <issuerName>Neuronetics, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>3222 PHOENIXVILLE PIKE</com:street1>
          <com:city>MALVERN</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19355</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This Amendment No. 2 to Schedule 13D ("Amendment No. 2") amends and supplements the Schedule 13D initially filed by the Reporting Person on March 31, 2026 (the "Original Schedule 13D") with respect to the Shares. Except as specifically amended and supplemented hereby, the Original Schedule 13D remains in full force and effect. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Original Schedule 13D.</commentText>
      </item1>
      <item3>
        <fundsSource>The 10,553,988 Shares held by Mr. Chernett were purchased with personal funds for an aggregate purchase price of approximately $20,619,936.</fundsSource>
      </item3>
      <item5>
        <percentageOfClassSecurities>The aggregate percentage of Shares beneficially owned by the Reporting Person is based upon 69,587,840 Shares outstanding as of May 1, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the "SEC") on May 5, 2026.

As of the close of business on May 26, 2026, the Reporting Person beneficially owned 10,553,988 Shares.

Percentage: Approximately 15.17%</percentageOfClassSecurities>
        <numberOfShares>1. Sole power to vote or direct vote: 10,553,988
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 10,553,988
4. Shared power to dispose or direct the disposition: 0</numberOfShares>
        <transactionDesc>The transactions in the Shares by the Reporting Person since the filing of Amendment No. 1 to the Schedule 13D are set forth in more detail in Exhibit 1 attached hereto.</transactionDesc>
        <listOfShareholders>No person other than the Reporting Person is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item7>
        <filedExhibits>Exhibit 1 - Transactions in the Securities</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Chernett Jorey</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jorey Chernett</signature>
          <title>Jorey Chernett</title>
          <date>05/27/2026</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
